EP1572: A novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man

Journal of Endocrinological Investigation - Tập 25 - Trang RC26-RC28 - 2014
F. Broglio1, F. Boutignon2, A. Benso1, C. Gottero1, F. Prodam1, E. Arvat1, C. Ghè3, F. Catapano3, A. Torsello4, V. Locatelli4, G. Muccioli3, D. Boeglin5, V. Guerlavais5, J. A. Fehrentz5, J. Martinez5, E. Ghigo1, R. Deghenghi2
1Divisione di Endocrinologia, Department of Internal Medicine, University of Turin, Italy
2Europeptides, Argenteuil, Universités Montpellier, France
3Departments of Anatomy, Pharmacol. and Forensic Medicine, University of Turin, Turin, Italy
4Department of Experimental and Environmental Medicine and Biotechnologies, University Milano-Bicocca, Milan, Italy
5Laboratoire des Aminoacides, Peptides et Protéines, Universités Montpellier, France

Tóm tắt

EP1572 (JMV1843 [Aib-DTrp-DgTrp-CHO]) is a new peptido-mimetic GH secretagogue (GHS) showing binding potency to the GHS-receptor in animal and human tissues similar to that of ghrelin and peptidyl GHS. EP1572 induces marked GH increase after sc administration in neonatal rats. Preliminary data in 2 normal young men show that: 1) acute iv EP1572 administration (1.0 μg/kg) induces strong and selective increase of GH levels; 2) single oral EP1572 administration strongly and reproducibly increases GH levels even after a dose as low as 0.06 mg/kg. Thus, EP1572 is a new peptido-mimetic GHS with potent and selective GH-releasing activity.

Tài liệu tham khảo

Kojima M., Hosoda H., Matsuo H., Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol. Metab. 2001, 12: 118–122. Smith R.G., Van der Ploeg L.H., Howard A.D., et al. Peptidomimetic regulation of growth hormone secretion. Endocr. Rev. 1997, 18: 621–645. Muccioli G., Tschöp M., Papotti M., et al. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur. J. Pharmacol. 2002, 440: 235–254. Kojima M., Hosoda H., Kangawa K. Purification and distribution of ghrelin: the natural endogenous ligand for the growth hormone secretagogue receptor. Horm. Res. 2001, 56: 93–97. Martinez J., Fehrentz J.A., Guerlavais V. Growth hormone secretagogues, PCT — WO 01/96300 A1, 20.12.2001 Muccioli G., Ghe C., Ghigo M.C., et al. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J. Endocrinol. 1998, 157: 99–106. Muccioli G., Papotti M., Locatelli V., Ghigo E., Deghenghi R. Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. J. Endocrinol. Invest. 2001, 24: RC7–RC9. Torsello A., Luoni M., Schweiger F., et al. Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release. Eur. J. Pharmacol. 1998, 360: 123–129. Arvat E., Maccario M., Di Vito L., et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J. Clin. Endocrinol. Metab. 2001, 86: 1169–1174.